Last Name


Search Results to Susana Chavez-Bueno

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Chavez-Bueno, Susana

keywords Pediatric Infectious Diseases
research overview Dr. Chavez-Bueno’s current research work focuses on the pathogenesis of E. coli sepsis in newborns. Her overall research goal is to identify novel virulence factors relevant to the pathogen’s ability to traverse the gut and invade the bloodstream causing neonatal sepsis. Her studies utilize in vitro and animal models designed to characterize the bacterial components that determine invasion and trafficking across intestinal epithelium and interact with gut specific immune regulators as potential therapeutic targets to decrease life-threatening neonatal E. coli disease. Dr. Chavez-Bueno is an elected member of the Society for Pediatric Research and member of the Infectious Diseases Society of America.

One or more keywords matched the following items that are connected to Chavez-Bueno, Susana

Item TypeName
Concept Hospitals, Pediatric
Concept Pediatrics
Academic Article Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.
Academic Article Antibacterial agents in pediatrics.
Academic Article Vancomycin dosage in overweight and obese children.
Academic Article Vancomycin Dosing and Pharmacokinetics in Postoperative Pediatric Cardiothoracic Surgery Patients.
Award or Honor Receipt Research Mentor Award
Award or Honor Receipt The Harris D. Riley, Jr. Pediatric Society’s Award
Grant An Evaluation of the Safety, Efficacy and Pharmacokinetics of Daptomycin in Pediatric Subjects Aged Seven to Seventeen Years with Complicated Skin and Skin Structure Infections Caused by Gram-Positive Pathogens
Grant Chemokines in RSV-Induced Airway Hyperresponsiveness
Grant A Comparative Evaluation of the Safety and Efficacy of Daptomycin versus Standard of Care in Pediatric Subjects Two-Seventeen Years of Age with Bacteremia Caused by Staphylococcus aureus
Grant Exposure to low pH Reveals Virulence Factors in Neonatal Escherichia coli Bacteremia after Oral Inoculation
Academic Article Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Academic Article Pediatric vaccines on the horizon.
Academic Article Bacterial meningitis in children.
Academic Article Respiratory syncytial virus: old challenges and new approaches.
Award or Honor Receipt Diversity, Equity & Inclusion Achievement Award

Search Criteria
  • Pediatric
  • Infectious Diseases